Cargando…

Early post‐treatment blood oxygenation level‐dependent responses to emotion processing associated with clinical response to pharmacological treatment in major depressive disorder

INTRODUCTION: Pre‐treatment blood oxygenation level‐dependent (BOLD) functional magnetic resonance imaging (fMRI) has been used for the early identification of patients with major depressive disorder (MDD) who later respond or fail to respond to medication. However, BOLD responses early after treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Rebecca J., Brown, Elliot C., Clark, Darren L., Pike, G. Bruce, Ramasubbu, Rajamannar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413787/ https://www.ncbi.nlm.nih.gov/pubmed/34333866 http://dx.doi.org/10.1002/brb3.2287

Ejemplares similares

Intrinsic thalamocortical connectivity varies in the age of onset subtypes in major depressive disorder
por: Brown, Elliot C, et al.
Publicado: (2018)

The impact of age of onset on amygdala intrinsic connectivity in major depression
por: Clark, Darren L, et al.
Publicado: (2018)

Methylphenidate modulates activity within cognitive neural networks of patients with post-stroke major depression: A placebo-controlled fMRI study
por: Ramasubbu, Rajamannar, et al.
Publicado: (2008)

Personality changes with subcallosal cingulate deep brain stimulation in patients with treatment-resistant depression
por: Ramasubbu, Rajamannar, et al.
Publicado: (2021)

Recruitment Challenges for Studies of Deep Brain Stimulation for Treatment-Resistant Depression
por: Ramasubbu, Rajamannar, et al.
Publicado: (2021)

Reduced Intrinsic Connectivity of Amygdala in Adults with Major Depressive Disorder
por: Ramasubbu, Rajamannar, et al.
Publicado: (2014)

Accuracy of automated classification of major depressive disorder as a function of symptom severity
por: Ramasubbu, Rajamannar, et al.
Publicado: (2016)

A Preliminary Study of the Influence of Age of Onset and Childhood Trauma on Cortical Thickness in Major Depressive Disorder
por: Jaworska, Natalia, et al.
Publicado: (2014)

Dosing of Electrical Parameters in Deep Brain Stimulation (DBS) for Intractable Depression: A Review of Clinical Studies
por: Ramasubbu, Rajamannar, et al.
Publicado: (2018)

Magnetoencephalographic Correlates of Emotional Processing in Major Depression Before and After Pharmacological Treatment
por: Domschke, Katharina, et al.
Publicado: (2015)

Treatment‐resistant major depressive disorder: Canadian expert consensus on definition and assessment
por: Rybak, Yuri E., et al.
Publicado: (2021)

The influence of 5-HTTLPR and Val66Met polymorphisms on cortical thickness and volume in limbic and paralimbic regions in depression: a preliminary study
por: Jaworska, Natalia, et al.
Publicado: (2016)

Pharmacological Treatment of Major Depressive Disorder in Adolescents
por: Farley, Rachel L.
Publicado: (2005)

Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder
por: Murrough, J W, et al.
Publicado: (2015)

Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews
por: Gartlehner, Gerald, et al.
Publicado: (2017)

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
por: Alvarez, Enric, et al.
Publicado: (2014)

Predictive Biomarkers of Treatment Response in Major Depressive Disorder
por: Stolz, Louise A., et al.
Publicado: (2023)

Counterfactual Thinking-Related Emotional Responses in Patients With Major Depressive Disorder
por: Zheng, Qi, et al.
Publicado: (2021)

Program of algorithm for pharmacological treatment of major depressive disorder in China: Benefits or not?
por: Zhu, Yuncheng, et al.
Publicado: (2023)

Understanding the emotions of patients with inadequate response to antidepressant treatments: results of an international online survey in patients with major depressive disorder
por: Mago, Rajnish, et al.
Publicado: (2018)

Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-Analysis
por: Brunoni, André Russowsky, et al.
Publicado: (2009)

The association of COMT genotype with buproprion treatment response in the treatment of major depressive disorder
por: Fawver, Jay, et al.
Publicado: (2020)

The Effects of Subliminal Goal Priming on Emotional Response Inhibition in Cases of Major Depression
por: Zhang, Man, et al.
Publicado: (2020)

Brain Regulation of Emotional Conflict Predicts Antidepressant Treatment Response for Depression
por: Fonzo, Gregory A., et al.
Publicado: (2019)

Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments
por: Maffioletti, Elisabetta, et al.
Publicado: (2020)

Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review
por: Shim, In Hee, et al.
Publicado: (2018)

Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review
por: Caldiroli, Alice, et al.
Publicado: (2021)

Assessment of pharmacological strategies for management of major depressive disorder and their costs after an inadequate response to first-line antidepressant treatment in primary care
por: Sicras-Mainar, Antoni, et al.
Publicado: (2012)

Gene expression biomarkers of response to citalopram treatment in major depressive disorder
por: Mamdani, F, et al.
Publicado: (2011)

Heart Rate Variability for the Prediction of Treatment Response in Major Depressive Disorder
por: Choi, Kwan Woo, et al.
Publicado: (2020)

Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder
por: Kang, Seung-Gul, et al.
Publicado: (2020)

6-Sulfatoxymelatonin predicts treatment response to fluoxetine in major depressive disorder
por: Jury Freitas, Juliana, et al.
Publicado: (2019)

Resting and TMS-EEG markers of treatment response in major depressive disorder: A systematic review
por: Strafella, Rebecca, et al.
Publicado: (2022)

SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli
por: Preuss, Antonia, et al.
Publicado: (2020)

Neurobiological and pharmacological arguments for customization of cognitive behavioral psychotherapy in the treatment of major depressive disorder
por: Ristea, Silvia, et al.
Publicado: (2021)

The effectiveness of electroconvulsive therapy in substance use disorder at pharmacological treatment failure major depression
por: Dannon, P.
Publicado: (2023)

Treatment patterns in major depressive disorder after an inadequate response to first-line antidepressant treatment
por: Garcia-Toro, Mauro, et al.
Publicado: (2012)

Role of emotional processing in depressive responses to sex-hormone manipulation: a pharmacological fMRI study
por: Henningsson, S, et al.
Publicado: (2015)

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
por: Rong, Carola, et al.
Publicado: (2018)

Pretreatment Brain Connectome Fingerprint Predicts Treatment Response in Major Depressive Disorder
por: Fan, Siyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hrr77v03io0he7tptls07uifv1